Adaptilens
PrivateLast Round
Series A
Apr 29, 2024
Total Funding Raised
$20.86M
Company Overview
Adaptilens is a medical device company that develops an innovative intraocular lens that mimics the natural human lens, providing patients with clear vision at all distances and reducing their reliance on glasses and contact lenses.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Biotechnology, Advanced Materials
Business Model
B2B
Customer Profile
Hardware Sales
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Adaptilens Comparables
Compare Adaptilens with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| LensGen | 90% | |
| JelliSee Ophthalmics Inc. | 90% | |
| Atia Vision | 89% | |
Adaptilens Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Apr 29, 2024 | ||||
| Grant | May 5, 2022 | ||||
| Grant | Jun 14, 2021 | ||||
| Seed | Nov 12, 2020 | ||||
| Seed | Aug 5, 2020 |
Key People
Founding team and executive leadership
Adaptilens Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Massachusetts Life Sciences Center | Grant |
| Pillar VC | Series A, Seed |
| Accanto Partners | Seed, Series A |
| 380 Cap | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Nov 12, 2020
$1.6M round led by Pillar VC
Adaptilens Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Adaptilens's valuation, stock price, and market status.